MIKI NAITO

Last Updated :2025/07/07

Affiliations, Positions
Graduate School of Biomedical and Health Sciences, Assistant Professor
E-mail
mikinaitohiroshima-u.ac.jp

Basic Information

Major Professional Backgrounds

  • 2024/04, Hiroshima university, Graduate School of Biomedical and Health Sciences, Assistant Professor
  • 2019/04, Graduate School of Biomedical and Health Sciences, Graduate student
  • 2018/04, JR Hiroshima hospital, Medical director
  • 2017/04, Mazda hospital, doctor
  • 2014/04, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, doctor
  • 2012/04, Hiroshima City Hiroshima Citizens Hospital, junior resident

Educational Backgrounds

  • Hiroshima university, Graduate School of Biomedical and Health Sciences, Japan, 2019/04, 2023/03
  • Hiroshima university, shccol of medicine, Japan, 2006/04, 2012/03

Academic Degrees

  • Hiroshima University

Research Activities

Academic Papers

  1. Robotic urologic applications of the hinotori™ surgical robot system, Asian Journal of Urology, 20241024
  2. Prolyl isomerase Pin1 promotes extracellular matrix production in hepatic stellate cells through regulating formation of the Smad3-TAZ complex, Exp Cell Res., 15(425), 202304
  3. ★, Par14 interacts with the androgen receptor, augmenting both its transcriptional activity and prostate cancer proliferation, Cancer Medicine, 12(7), 8464-8475, 202304
  4. The expression of prolyl isomerase Pin1 is expanded in the skin of patients with atopic dermatitis and facilitates IL-33 expression in HaCaT cells, J. Dermatol., 50(4), 462-471, 202304
  5. Prolyl isomerase Pin1 interacts with adipose triglyceride lipase and negatively controls both its expression and lipolysis, Metabolism, 115, 202012
  6. Pin1 Plays Essential Roles in NASH Development by Modulating Multiple Target Proteins, cells, 8(12), 2019
  7. Huge urinoma caused by spontaneous ureteral rupture secondary to ureteral obstruction due to prostate cancer, Asian J Urol, 2019
  8. Bone scan index can be a useful biomarker of survival outcomes in patients with metastatic castration-resistant prostate cancer treated with radium-223, Cancer Reports, 2(5), 201907

Invited Lecture, Oral Presentation, Poster Presentation

  1. Prolyl isomerase Par14 associates with DNA-binding domain of the androgen receptor, enhancing both its transcriptional activity and prostate cancer proliferation, 2023/11, Without Invitation, Japanese
  2. Par14 interacts with the androgen receptor, augmenting both its transcriptional activity and prostate cancer proliferation, Miki Naito, Kenichiro Ikeda, Yasuyuki Akasaka, Akio Matsubara, Tomoichiro Asano, Yusuke Nakatsu, Nobuyuki Hinata, 2023/04, Without Invitation, Japanese

External Funds

Acceptance Results of Competitive Funds

  1. 2024
  2. 2023